At a glance
ClinicalIndex Comparison RecordN/ACompleted· 81 enrolled
Drug / intervention
Model SN60WF +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Contralateral Clinical Trial With Single-piece (SN60WF) vs. Three Piece (MA60AC) AcrySof Intraocular Lenses (IOLs) on Development of Posterior Chamber Opacification (PCO).
In Brief
A clinical study evaluating Model SN60WF and Model MA60AC for Cataract. Completed, enrolled 81 participants across 1 site.
Detailed Summary
Randomized contralateral clinical trial with single piece (Model SN60WF) vs. three piece (Model MA60AC) AcrySof Intraocular Lenses (IOLs) on development of Posterior Chamber Opacifiation (PCO).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2006
First PostedSep 2008
Primary CompletionDec 2009
TodayJul 2026
First PostedSep 25, 2008
Enrollment StartJan 1, 2006
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 17.8 years ago
Interventions
Model SN60WFdevice
Implantation with the AcrySof Model SN60WF Single-piece intraocular lens (IOL) following cataract removal.
Model MA60ACdevice
Implantation with the AcrySof Model MA60AC multi-piece intraocular lens (IOL) following cataract surgery.